1-(2,5-Dimethyl-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea

ID: ALA4870044

PubChem CID: 164622412

Max Phase: Preclinical

Molecular Formula: C21H20F3N5O2

Molecular Weight: 431.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1cc(Oc2cc(C)c(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2C)ncn1

Standard InChI:  InChI=1S/C21H20F3N5O2/c1-12-8-17(31-19-10-18(25-3)26-11-27-19)13(2)7-16(12)29-20(30)28-15-6-4-5-14(9-15)21(22,23)24/h4-11H,1-3H3,(H,25,26,27)(H2,28,29,30)

Standard InChI Key:  UEOWFEBVIKGTDJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   10.8304  -20.9481    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.4220  -21.6649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2468  -21.6601    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.1362  -20.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1351  -21.2962    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5635  -20.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8481  -20.0560    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2766  -20.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9927  -20.4598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9924  -21.2825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7077  -21.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4217  -21.2770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4158  -20.4477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7001  -20.0416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1383  -21.6860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8508  -21.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5673  -21.6786    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8465  -20.4447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2797  -21.2624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9945  -21.6731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7065  -21.2577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7027  -20.4318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9811  -20.0230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2721  -20.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5710  -21.2955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8491  -21.7070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8475  -22.5321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5612  -22.9460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4267  -22.4920    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6926  -19.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7104  -22.5174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5 26  1  0
 25  6  1  0
  6  7  2  0
  7  4  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 21  2  1  0
  2 29  1  0
 14 30  1  0
 11 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4870044

    ---

Associated Targets(Human)

TNNI3K Tchem Serine/threonine-protein kinase TNNI3K (615 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 431.42Molecular Weight (Monoisotopic): 431.1569AlogP: 5.59#Rotatable Bonds: 5
Polar Surface Area: 88.17Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.56CX Basic pKa: 4.78CX LogP: 5.26CX LogD: 5.26
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.49Np Likeness Score: -1.82

References

1. Patterson JR, Graves AP, Stoy P, Cheung M, Desai TA, Fries H, Gatto GJ, Holt DA, Shewchuk L, Totoritis R, Wang L, Kallander LS..  (2021)  Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf.,  64  (21.0): [PMID:34699203] [10.1021/acs.jmedchem.1c00700]

Source